Refiners Continue T...
Health Care: Health Services
Genomic Health Inc. (GHDX: NASDAQ)
$37.00 0.00 | 0.00%
05/24/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 37.00 |
| 52 Week High | 37.64 |
| 52 Week Low | 25.25 |
| Avg. Daily Vol. (Mil) | 0.22 |
| Beta (3 year) | 0.34 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,118.04 |
| Shares Out (Mil) | 30.22 |
| Float (Mil) | 16.73 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.00 |
| Current Ratio | 5.40 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 185.00 |
| Price/Sales | 4.66 |
| Price/Book | 8.56 |
| Price/Cash Flow | 87.00 |
| Per Share Data | |
| Earnings | 0.20 |
| Sales | 7.94 |
| Book Value | 4.32 |
| Cash Flow | 0.43 |
| Business Summary | |
|---|---|
| Genomic Health, Inc. develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. | |
| General Information | |
| 301 Penobscot Drive
Redwood City, CA 94063 |
|
| www.genomichealth.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 612 | |
| CEO: Kimberly J. Popovits | |
| Short Interest | |
| Current Month (Mil) | 2.80 |
| Previous Month (Mil) | 2.50 |
| Short Interest Ratio (Days) | 16.40 |
| Management Effectiveness | |
| Return on Equity | 5.60 |
| Return on Assets | 4.70 |
| Return on Investments | 5.60 |
| Profitability | |
| Gross Margin | 86.70 |
| EBIT Margin | 2.90 |
| Profit Margin | 3.10 |
Portfolios with GHDX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
Latest GHDX Headlines from TheStreet
- 4 Stocks Rising on Unusual Volume 03.29.13 | 07:03 am
- Top Insider Trades: GHDX, CLMS, IRM, FAST 02.22.13 | 09:02 am
- 5 Stocks With Big Insider Buying 02.13.13 | 12:02 pm
- 5 Stocks Poised for Breakouts 01.04.13 | 01:01 pm
- Short Sellers Are More Bullish About These Hedge Fund Favorites 12.20.12 | 04:12 pm
- 11 Stocks With Significant Institutional And Insider Buying 12.18.12 | 06:12 pm
- 10 Stocks With Bullish Institutional And Insider Buying Activities 12.04.12 | 04:12 pm
- Insiders Trading GHDX TZOO INFN KKD 11.26.12 | 09:11 am
- 5 Stocks Insiders Are Snapping Up 11.21.12 | 12:11 pm
- Insiders Trading GHDX ASCMA GNC SNTA 11.15.12 | 09:11 am
Press Releases for GHDX
- Genomic Health Announces Publication Of Second Positive Validation Of Oncotype DX Colon Cancer Test Confirming Its Value Beyond Conventional Markers - PR Newswire 04.17.13 | 08:04 am
- Genomic Health To Address One Of The Most Significant Needs In Men's Health With The Oncotype DX® Prostate Cancer Test - PR Newswire 04.03.13 | 08:04 am
- Genomic Health Presents Twenty Two International Studies Demonstrating Worldwide Adoption And Value Of Oncotype DX® Breast Cancer Test - PR Newswire 03.15.13 | 08:03 am
- Genomic Health Announces Positive Results From Large Study Of Oncotype DX® To Quantify Risk Of Loco-Regional Recurrence In Node-positive Breast Cancer Patients And Acceptance Of Oncotype DX DCIS Validation Study For Publication - PR Newswire 03.13.13 | 08:03 am
- Genomic Health Announces Results From Two Studies Demonstrating Innovations In Next Generation Sequencing From Paraffin Tissue, Enhancing Understanding Of Tumor Biology - PR Newswire 02.25.13 | 08:02 am
- Genomic Health To Announce Fourth Quarter And Year-End 2012 Financial Results And Host Conference Call On Wednesday, February 6, 2013 - PR Newswire 01.30.13 | 08:01 am
- Genomic Health Announces New Evidence Further Demonstrating Clinical Utility And Cost-Effectiveness Of Oncotype DX In Colon Cancer - PR Newswire 01.23.13 | 08:01 am
- Genomic Health To Present At The J.P. Morgan Healthcare Conference - PR Newswire 12.21.12 | 08:12 am
- Genomic Health Announces Presentation Of Six Studies At The 2012 CTRC-AACR San Antonio Breast Cancer Symposium - PR Newswire 11.28.12 | 08:11 am
- Genomic Health To Present At Two Upcoming Investor Conferences - PR Newswire 11.09.12 | 08:11 am
Partner Headlines for GHDX
- Genomic Health, Inc. Enters Oversold Territory - Tale of the Tape - NASDAQ 09.12.12 | 03:09 pm
- Cepheid Remains Neutral - Analyst Blog - NASDAQ 08.22.12 | 06:08 pm
- Agilent Wins Patent in US - Analyst Blog - NASDAQ 08.21.12 | 07:08 pm
- Genomic Health Back to Neutral - Analyst Blog - NASDAQ 08.20.12 | 11:08 pm
- Genomic Health Beats on EPS - Analyst Blog - Zacks 08.09.12 | 10:08 am
- CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares - GuruFocus 07.13.12 | 02:07 pm
- Medical Sector Shows Muscle With SXC Health, Cerner - Investor's Business Daily 06.21.12 | 06:06 pm
- 4 Stocks With Heavy Insider Buying - Seeking Alpha 02.24.12 | 08:02 am
- Myriad Beats, Raises Guidance - Analyst Blog - Zacks 02.01.12 | 09:02 am
- 17 Breakout Stocks Boosted By Insiders - Seeking Alpha 12.30.11 | 04:12 pm
